文献速递心律失常

房颤密度作为缺血性卒中风险预测的生物标志物

Atrial fibrillation density as a biomarker for ischaemic stroke risk prediction.
PubMed 文献 · Eur Heart J · 2026-01-01

研究评估30天间隔内的房颤密度与1年缺血性卒中风险的关联,发现房颤密度与卒中风险呈剂量反应关系,独立于房颤负荷并改善风险分层。

要点

  • 房颤密度越高,1年缺血性卒中风险越大,呈剂量反应关系。
  • 在各房颤负荷水平内,高密度患者卒中风险均更高。
  • 评估房颤密度可辅助更精准的卒中风险分层与个体化预防。

核心结论

  • 房颤密度与缺血性卒中呈独立于房颤负荷的剂量反应关系,并可改善卒中风险分层。

研究设计与样本

  • 利用美国退伍军人健康管理局和北卡罗来纳大学两个远程监测心脏植入式电子设备的队列数据,时间为2010年1月至2025年5月。

主要发现

  • 房颤密度与1年卒中风险呈剂量反应关系,风险比为1.75(95%置信区间1.25-2.44)。
  • 该关联在不同设备类型、合并症、年龄和抗凝状态间保持一致;在每一房颤负荷水平内,高密度患者卒中风险均更高。

关键数值与推荐

  • 房颤密度定义为30天间隔内房颤发作的时间分布,范围0(分散发作)至1(集中发作),分为低(>0-0.3)、中(>0.3-0.6)、中高(>0.6-0.9)和高(>0.9-1.0)。
  • 房颤负荷定义为处于房颤状态的时间百分比,在30天间隔内评估。

临床怎么用

  • 除评估房颤负荷外,可同时评估房颤密度以辅助缺血性卒中风险分层。
  • 高密度房颤患者可能需要更积极的卒中预防策略,即使其房颤负荷较低。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND AIMS: Atrial fibrillation (AF) is frequently classified by episode duration and cumulative burden, yet these methods fail to characterize temporal episode distribution (AF density), which may be more clinically relevant and prognostically important. This study evaluated AF density's association with ischaemic stroke and whether it improves risk stratification compared with AF burden. METHODS: Data from two US cohorts with cardiac implantable electronic devices remotely monitored by the Veterans Health Administration and University of North Carolina (January 2010-May 2025) were analysed. AF burden (percentage of time in AF) and density [range: 0 (dispersed episodes) to 1 (consolidated episodes)] were assessed in 30-day intervals and categorized as low (>0-0.3), medium (>0.3-0.6), medium-high (>0.6-0.9), and high (>0.9-1.0). Patients with permanent AF or no episodes ≥6 min were excluded. G-formula modelling estimated 1-year stroke risk ratios (RRs), adjusting for baseline and time-varying covariates. Results were pooled using random-effects meta-analysis. RESULTS: Of 41 780 patients, 12 868 met inclusion criteria (mean age 72.0 years; median CHA2DS2-VASc 4.0); 336 experienced ischaemic stroke over a median 4.0-year follow-up (6.3 per 1000 person-years). Atrial fibrillation density demonstrated a dose-response relationship with 1-year stroke risk (RR 1.75; 95% confidence interval 1.25-2.44) and findings were consistent across device types, comorbidities, age, and anticoagulation status. At each level of AF burden, patients with high density exhibited greater stroke risk. CONCLUSIONS: Atrial fibrillation density demonstrated robust dose-response relationships with ischaemic stroke independent of AF burden and enhanced risk stratification, suggesting that density may enable more precise stroke risk assessment and personalized prevention strategies.

来源:Eur Heart J,查看原文。版权归原作者所有。

引用

  1. Rosman, Wang, Sarkar, et al. Atrial fibrillation density as a biomarker for ischaemic stroke risk prediction. Eur Heart J. 2026. PMID: 41895321. doi:10.1093/eurheartj/ehag203

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。